KAWAS LEEN purchased 0.6% of their position (24.33K shares) of EIGER BIOPHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $6.4K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/2/2023ACC: 0001140361-23-051260
10% Owner
Since Oct 2023
+24.33K
Net shares
Net buyer
$6.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
24.33K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+11.99K
Price / share
$0.26
Trade value
$3.15K
% of position
0.3%
10/31/2023
4.37M→4.38M
Common Stock
Indirect
Shares
+12.35K
Price / share
$0.26
Trade value
$3.23K
% of position
0.3%
10/31/2023
4.38M→4.39M
Total
Net shares
+24.33K
Net value
$6.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/31/2023 | P · Purchase | +11.99K | $0.26 | $3.15K | 0.3% | 4.37M | 4.38M |
| Common Stock Indirect | 10/31/2023 | P · Purchase | +12.35K | $0.26 | $3.23K | 0.3% | 4.38M | 4.39M |
| Total | +24.33K | $6.37K | ||||||
Derivative Transactions0
No derivative transactions reported